Cargando…
Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431915/ https://www.ncbi.nlm.nih.gov/pubmed/32540951 http://dx.doi.org/10.1136/rmdopen-2020-001184 |
_version_ | 1783571679279054848 |
---|---|
author | Hillen, Maarten R Urso, Katia Koppe, Emma Lopes, Ana Pinheiro Blokland, Sofie L M Pandit, Aridaman Slocombe, Tom van Maurik, André van Roon, Joel A G Radstake, Timothy R D J |
author_facet | Hillen, Maarten R Urso, Katia Koppe, Emma Lopes, Ana Pinheiro Blokland, Sofie L M Pandit, Aridaman Slocombe, Tom van Maurik, André van Roon, Joel A G Radstake, Timothy R D J |
author_sort | Hillen, Maarten R |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7431915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-74319152020-08-24 Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity Hillen, Maarten R Urso, Katia Koppe, Emma Lopes, Ana Pinheiro Blokland, Sofie L M Pandit, Aridaman Slocombe, Tom van Maurik, André van Roon, Joel A G Radstake, Timothy R D J RMD Open Sjögren Syndrome BMJ Publishing Group 2020-06-15 /pmc/articles/PMC7431915/ /pubmed/32540951 http://dx.doi.org/10.1136/rmdopen-2020-001184 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Sjögren Syndrome Hillen, Maarten R Urso, Katia Koppe, Emma Lopes, Ana Pinheiro Blokland, Sofie L M Pandit, Aridaman Slocombe, Tom van Maurik, André van Roon, Joel A G Radstake, Timothy R D J Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity |
title | Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity |
title_full | Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity |
title_fullStr | Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity |
title_full_unstemmed | Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity |
title_short | Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity |
title_sort | autoantigen trim21/ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in sjögren’s syndrome is associated with b cell hyperactivity and type i interferon activity |
topic | Sjögren Syndrome |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431915/ https://www.ncbi.nlm.nih.gov/pubmed/32540951 http://dx.doi.org/10.1136/rmdopen-2020-001184 |
work_keys_str_mv | AT hillenmaartenr autoantigentrim21ro52isexpressedonthesurfaceofantigenpresentingcellsanditsenhancedexpressioninsjogrenssyndromeisassociatedwithbcellhyperactivityandtypeiinterferonactivity AT ursokatia autoantigentrim21ro52isexpressedonthesurfaceofantigenpresentingcellsanditsenhancedexpressioninsjogrenssyndromeisassociatedwithbcellhyperactivityandtypeiinterferonactivity AT koppeemma autoantigentrim21ro52isexpressedonthesurfaceofantigenpresentingcellsanditsenhancedexpressioninsjogrenssyndromeisassociatedwithbcellhyperactivityandtypeiinterferonactivity AT lopesanapinheiro autoantigentrim21ro52isexpressedonthesurfaceofantigenpresentingcellsanditsenhancedexpressioninsjogrenssyndromeisassociatedwithbcellhyperactivityandtypeiinterferonactivity AT bloklandsofielm autoantigentrim21ro52isexpressedonthesurfaceofantigenpresentingcellsanditsenhancedexpressioninsjogrenssyndromeisassociatedwithbcellhyperactivityandtypeiinterferonactivity AT panditaridaman autoantigentrim21ro52isexpressedonthesurfaceofantigenpresentingcellsanditsenhancedexpressioninsjogrenssyndromeisassociatedwithbcellhyperactivityandtypeiinterferonactivity AT slocombetom autoantigentrim21ro52isexpressedonthesurfaceofantigenpresentingcellsanditsenhancedexpressioninsjogrenssyndromeisassociatedwithbcellhyperactivityandtypeiinterferonactivity AT vanmaurikandre autoantigentrim21ro52isexpressedonthesurfaceofantigenpresentingcellsanditsenhancedexpressioninsjogrenssyndromeisassociatedwithbcellhyperactivityandtypeiinterferonactivity AT vanroonjoelag autoantigentrim21ro52isexpressedonthesurfaceofantigenpresentingcellsanditsenhancedexpressioninsjogrenssyndromeisassociatedwithbcellhyperactivityandtypeiinterferonactivity AT radstaketimothyrdj autoantigentrim21ro52isexpressedonthesurfaceofantigenpresentingcellsanditsenhancedexpressioninsjogrenssyndromeisassociatedwithbcellhyperactivityandtypeiinterferonactivity |